INmune Bio publishes preclinical study on XPro1595 and brain injury
Go back to INmune Bio publishes preclinical study on XPro1595 and brain injury| (NASDAQ: INMB) | Delayed: 1.72 -0.12 (6.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.84 | 52 Week High | $ | |||
| Open | $1.80 | 52 Week Low | $ | |||
| Day High | $1.81 | P/E | N/A | |||
| Day Low | $1.69 | EPS | $ | |||
| Volume | 313,939 | |||||
